Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma Why Is Small Cancer-Drug Developer Kinnate Biopharma (KNTE) Stock Up Today? – XOMA (NASDAQ:XOMA), Kinnate Biopharma (NASDAQ:KNTE)
Friday, XOMA Corporation XOMA agreed to acquire Kinnate Biopharma Inc KNTE for a base cash price of $2.3352 per share and an additional cash amount of not more than $0.2527 per share plus a…